This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study. (19th April 2022)
Record Type:
Journal Article
Title:
Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study. (19th April 2022)
Main Title:
Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study
Abstract : Dupilumab associated head and neck dermatitis is incompletely understood. This prospective multicentre prospective study identified baseline Malassezia ‐specific IgE as associated with the development of Dupilumab associated head and neck dermatitis.